WealthCare Investment Partners LLC Boosts Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

WealthCare Investment Partners LLC boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,275 shares of the financial services provider’s stock after buying an additional 94 shares during the quarter. WealthCare Investment Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,051,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Vigilant Capital Management LLC acquired a new stake in iShares Biotechnology ETF during the 1st quarter valued at $26,000. WealthPLAN Partners LLC acquired a new position in iShares Biotechnology ETF during the 1st quarter worth $27,000. Thompson Investment Management Inc. acquired a new position in iShares Biotechnology ETF during the 1st quarter worth $38,000. Red Lighthouse Investment Management LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth $39,000. Finally, Lakewood Asset Management LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth $39,000. 69.61% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 0.3 %

Shares of NASDAQ IBB traded up $0.34 during midday trading on Tuesday, hitting $125.59. The company’s stock had a trading volume of 725,462 shares, compared to its average volume of 1,514,015. The firm’s fifty day moving average price is $128.05 and its 200-day moving average price is $129.30. iShares Biotechnology ETF has a 1-year low of $113.37 and a 1-year high of $138.74.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.